A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
about
Drugs as important factors causing allergiesDrug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current conceptsCutaneous adverse drug reactions in Indian population: A systematic review.Increased adverse drug reactions to antimicrobials and anticonvulsants in patients with HIV infection.Red herring in returned traveler: drug reaction with eosinophilia and systemic symptom (DRESS) syndrome mimicking sepsis.Drug Reaction with Eosinophilia and Systemic Symptoms: DRESS following Initiation of Oxcarbazepine with Elevated Human Herpesvirus-6 Titer.Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactionsSevere cutaneous reactions to drugs in the setting of a general hospital.Drug hypersensitivity in students from São Paulo, Brazil.Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.Adverse cutaneous drug reactions: Eight year assessment in hospitalized patientsDrug-induced anaphylactic reactions in Indian population: A systematic review.DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin.Epidemiology and risk factors for drug allergy.Drug-induced skin reactions: a 2-year study.Lamotrigine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in TurkeyAdverse drug reaction reporting in a pharmacovigilance centre of Nepal.Nitrofurantoin: cause of DRESS syndrome.Acute tubular necrosis as a part of vancomycin induced drug rash with eosinophilia and systemic symptoms syndrome with coincident postinfectious glomerulonephritis.Diphenylhydantoin Induced DRESS Syndrome: A Case Report.Antibiotic allergies in the medical record: effect on drug selection and assessment of validity.The prevalence and reliability of self-reported penicillin allergy in a community hospital.DRESS syndrome following ciprofloxacin exposure: An unusual associationSkin manifestations of drug allergy.Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study.Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.Severe adverse cutaneous drug eruptions: epidemiological and clinical features.Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis.DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report.Adverse cutaneous drug reactions in a single quaternary referral hospital.A case of drug reaction with eosinophilia and systemic symptoms.Incidence of adverse cutaneous drug reactions in 22,866 Chinese inpatients: a prospective study.Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study.Is drug allergy less prevalent than previously assumed? A 5-year analysis.
P2860
Q26772202-59002CA9-6A47-4E73-B565-2E437F040BB4Q27030788-0552345D-733B-42C8-9586-8ADC5439256BQ30408574-CDD2E47C-E5C4-40D4-BD6E-B4864952C935Q33254111-633D2CB4-43B9-4DAC-AD23-3CB6D12D2451Q33418396-EDBBB61C-464E-46A1-925F-EA9D25BA13F5Q33552260-748882A5-5B3C-4AE4-A48A-063DA9EA0137Q33777950-1489CC9A-D39C-4187-BDDE-D0694F870D27Q33788588-95E09C83-41DA-405A-BDE3-6D6BC1EFB5FEQ34140503-5B2BB604-18C1-4658-BCCA-9A616A0F6A99Q34275219-295715B6-363F-4F29-BE65-A04AE7981C60Q34466478-609755FD-F597-4ABB-B043-986A570E635EQ34529792-8AC33933-4311-4F70-A382-09FB2552A8BCQ34738323-E9A27F88-E66E-4F70-88B7-6412954FE0EDQ34945847-DFCD62B7-E3E7-498C-AB70-07C0811198FEQ34976470-9241DBEB-9DCF-4C11-B42D-F549A29CF472Q35087887-7C7A37EE-0DE7-4AD1-9C40-EED9D439D36EQ35699761-6E07CAB2-1DB2-44CB-B584-158B4114F005Q36021140-8A421457-7777-4312-B305-78D160801643Q36090861-BD727A04-C362-4792-B814-5351D9931993Q36893956-E5C581FA-18AF-474E-9FFA-01E05C510C3DQ36897302-50F954F3-C516-46B6-AE6F-A54A011F9571Q36971926-A2DA86BE-3329-42CA-AEA1-2FDDCEE71AD3Q37310473-6FDF9A8E-3D04-4E5F-9F9D-746BE4272418Q37378369-084995C9-12B1-491A-A173-C5BD14122B17Q37380815-D349225E-C1E7-4D5F-A67F-364A8F20C641Q37863710-32588CA8-E096-4E45-AB01-6DF6C7AB2B71Q37869453-BB0E3BDE-51E3-4772-9058-DAA8F212B301Q38003494-AB16110B-62EB-4F60-93E9-ADC1A7448DF1Q38829886-8EC6C83E-214D-41CE-B9DC-594D537ACAC2Q39069483-9508DFDC-109B-4BA3-8C48-207FFF0044CCQ39110729-7ACE1CD1-C576-4E48-884B-CD0ECA05BDE4Q39622892-5CA25D88-FB17-4504-BBBA-A16142812266Q40088058-0A56DD46-2D0C-4EEF-88D6-F516A97A8802Q40090987-6D98AE8C-95B3-4004-B97D-783B7DD8C062Q40164966-91E0E5BD-77C2-4DA3-B7D7-AE182FAD43EFQ40274909-0B8226C7-31F6-4403-BD17-B8C8C519D448Q40656065-0D9630E8-572A-42B1-B726-A2F082E78CE4Q42974916-219A5362-3DCC-411A-8FD6-69BBC7EFE1CCQ43749235-2AD858B0-DA0B-431B-9CF8-7B398F0F715CQ43809857-E5592D15-8723-44C0-B66D-5BF9F89908FB
P2860
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
@en
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
@nl
type
label
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
@en
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
@nl
prefLabel
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
@en
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
@nl
P2093
P1476
A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
@en
P2093
Descamps V
Durand-Stocco C
Farinotti R
Fiszenson-Albala F
P304
P356
10.1111/J.1365-2133.2003.05584.X
P407
P577
2003-11-01T00:00:00Z